Founders Capital Management (Texas)’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Hold |
2,000
| – | – | 0.01% | 238 |
|
|
2025
Q1 | $14.7K | Hold |
2,000
| – | – | 0.01% | 251 |
|
|
2024
Q4 | $17.1K | Hold |
2,000
| – | – | 0.01% | 240 |
|
|
2024
Q3 | $17.4K | Hold |
2,000
| – | – | 0.01% | 248 |
|
|
2024
Q2 | $13.7K | Hold |
2,000
| – | – | 0.01% | 264 |
|
|
2024
Q1 | $18.2K | Hold |
2,000
| – | – | 0.01% | 241 |
|
|
2023
Q4 | $8.92K | Sell |
2,000
-1,500
| -43% | -$6.69K | 0.01% | 296 |
|
|
2023
Q3 | $11K | Hold |
3,500
| – | – | 0.01% | 288 |
|
|
2023
Q2 | $18.1K | Hold |
3,500
| – | – | 0.01% | 248 |
|
|
2023
Q1 | $18K | Buy |
3,500
+1,000
| +40% | +$5.14K | 0.01% | 248 |
|
|
2022
Q4 | $7K | Hold |
2,500
| – | – | 0.01% | 325 |
|
|
2022
Q3 | $10K | Hold |
2,500
| – | – | 0.01% | 298 |
|
|
2022
Q2 | $10K | Buy |
+2,500
| New | +$10K | 0.01% | 309 |
|